Cargando…
Blood Group O Protect End-Stage Renal Disease Patients With Dialysis From Coronary Artery Disease
OBJECTIVE: Our study aims to investigate the role of the ABO blood group in the development and severity of coronary artery disease (CAD) in end-stage renal disease (ESRD) patients with dialysis. METHODS: A total of 408 ESRD patients with dialysis between January 2010 and December 2020 were enrolled...
Autores principales: | Ye, Zixiang, Wu, Yaxin, Tu, Yimin, Chen, Mulei, Gao, Yanxiang, Shi, Linying, Li, Peizhao, Xie, Enmin, Guo, Ziyu, Li, Qing, Yu, Xiaozhai, Li, Yike, Niu, Wenquan, Ren, Jingyi, Zheng, Jingang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8837269/ https://www.ncbi.nlm.nih.gov/pubmed/35155621 http://dx.doi.org/10.3389/fcvm.2021.821540 |
Ejemplares similares
-
Predictive Value of the CHA(2)DS(2)-VASc Score for Mortality in Hospitalized Acute Coronary Syndrome Patients With Chronic Kidney Disease
por: Wu, Yaxin, et al.
Publicado: (2022) -
The triglyceride glucose index is associated with future cardiovascular disease nonlinearly in middle-aged and elderly Chinese adults
por: Ye, Zixiang, et al.
Publicado: (2022) -
Triglyceride glucose index exacerbates the risk of future cardiovascular disease due to diabetes: evidence from the China Health and Retirement Longitudinal Survey (CHARLS)
por: Ye, Zixiang, et al.
Publicado: (2022) -
Empagliflozin inhibits coronary microvascular dysfunction and reduces cardiac pericyte loss in db/db mice
por: Tu, Yimin, et al.
Publicado: (2022) -
Ticagrelor vs. clopidogrel for coronary microvascular dysfunction in patients with STEMI: a meta-analysis of randomized controlled trials
por: Li, Yike, et al.
Publicado: (2023)